STOCK TITAN

Eargo to Report First Quarter 2023 Financial Results on May 11, 2023

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary
Eargo, Inc. (Nasdaq: EAR) will release financial results for Q1 2023 on May 11, 2023, followed by a conference call and webcast to discuss the results.
Positive
  • Eargo will release financial results for Q1 2023, which could positively impact the stock price if the results exceed expectations.
Negative
  • None.

SAN JOSE, Calif., May 04, 2023 (GLOBE NEWSWIRE) -- Eargo, Inc. (Nasdaq: EAR), a medical device company on a mission to improve hearing health, today announced it will release financial results for the first quarter 2023 after market close on May 11, 2023. On the same day, Eargo will host a conference call and webcast at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers, using conference ID: 2789592. The live webinar of the call may also be accessed by visiting the Events and Presentations section of Eargo’s website at ir.eargo.com. A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Eargo’s website for one year.

About Eargo
Eargo is a medical device company on a mission to improve hearing health. Our innovative products and go-to-market approach address the major challenges of traditional hearing aid adoption, including social stigma, accessibility and cost. We believe our Eargo hearing aids are the first virtually invisible, rechargeable, completely-in-canal, FDA-regulated devices indicated to compensate for mild to moderate hearing loss. Our differentiated, consumer-first approach empowers consumers to take control of their hearing. Consumers can purchase online, at retail locations or over the phone and get personalized and convenient consultation and support from hearing professionals via phone, text, email or video chat. Eargo hearing aids are offered to consumers at approximately half the cost of competing hearing aids purchased through traditional channels in the United States.

Eargo’s seventh generation device, Eargo 7, is an FDA 510(k) cleared, self-fitting over-the-counter hearing aid featuring Sound Adjust+ with Comfort and Clarity Modes, which focuses on noise reduction and adapting to the user’s environment and needs. Eargo 7 is available for purchase here.

Related Links
http://eargo.com

Investor Contact
Nick Laudico
Chief Retail Officer
ir@eargo.com


FAQ

When will Eargo release its financial results for Q1 2023?

Eargo will release its financial results for Q1 2023 on May 11, 2023.

What will Eargo discuss during the conference call and webcast?

Eargo will discuss its financial results and recent highlights during the conference call and webcast.

How can I access the live call?

You can access the live call by dialing (800) 715-9871 for domestic callers or (646) 307-1963 for international callers, using conference ID: 2789592.

Where can I access the live webinar of the call?

You can access the live webinar of the call on Eargo's website at ir.eargo.com.

Will there be a replay of the webinar?

Yes, a replay of the webinar will be available on Eargo's website shortly after the conclusion of the call and will be archived for one year.

Eargo, Inc.

NASDAQ:EAR

EAR Rankings

EAR Latest News

EAR Stock Data

53.36M
3.81M
5.43%
6.39%
0.2%
Medical Devices
Healthcare
Link
United States
San Jose